Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX4 | Q99571 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10037576 | 0.71 | — | — | |
| SCHEMBL10037569 | 0.70 | ALDH1A1 (0.35) | ALDH1A1MAPT | |
| SCHEMBL10037551 | 0.69 | POLB (0.38) | ALDH1A1MAPT | |
| SCHEMBL27305181 | 0.69 | MGLL (0.35) | ALDH1A1MAPT | |
| SCHEMBL18639135 | 0.68 | RIPK1 (0.32) | P2RX4 | |
| SCHEMBL11509113 | 0.68 | MGLL (0.38) | ALDH1A1MAPT | |
| SCHEMBL24571415 | 0.67 | GSK3A (0.30) | — | |
| SCHEMBL10473664 | 0.67 | MAPT (0.31) | MAPT | |
| SCHEMBL7962613 | 0.66 | MGLL (0.36) | ALDH1A1MAPT | |
| SCHEMBL18391260 | 0.66 | MGLL (0.36) | ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8124791-B2 | Active energy ray curable liquid composition and liquid cartridge | CANON KABUSHIKI KAISHA (JP) | 2012-02-28 | — | — | US | disclosed |
| US-20100094024-A1 | ACTIVE ENERGY RAY CURABLE LIQUID COMPOSITION AND LIQUID CARTRIDGE | CANON KABUSHIKI KAISHA (JP) | 2010-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100094024-A1 | ACTIVE ENERGY RAY CURABLE LIQUID COMPOSITION AND LIQUID CARTRIDGE | C9, MLX, CHRM1 | P2RX4 2312/4885ALDH1A1 3555/4885MAPT 1636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.